Part IThe Story
On Saturdays the dollar went to town. It was silver. It belonged to a man in West Tennessee who had worked for a subsidiary of General Motors until 1929, when he lost that job the way so many men lost theirs that year. After that he farmed with his brother, and his children worked the rows beside them. The coin went into town in his pocket for one purpose, and the purpose was to come home again. Nobody needed it to buy anything. It was there in case. Decades later his eldest son, by then the retired chairman of a medical-technology company whose sales had grown from $17 million to $6.7 billion under his hand, described the ritual to a trade reporter almost word for word: When I think of frugality, I think of my dad, who carried a silver dollar to town on Saturdays hoping that he wouldn't have to spend it.
The son is John W. Brown. For thirty-two years, from February 1977 until he announced his retirement in October 2009, he ran or chaired the Stryker Corporation of Kalamazoo, Michigan. He took over a maker of turning frames, stretchers, and cast cutters, a company whose founding family had just been broken by a plane crash. He left behind a global orthopedic and surgical franchise that a successor management would carry past $25 billion in annual revenue. Forbes put him at No. 320 on its 2005 list of the richest Americans, at $1.1 billion, and called him "self made." Its one-paragraph summary of his life began with the phrase "Hired hand from small Tennessee town," which is accurate and also a little unkind, the way Forbes summaries tend to be.
He did all of this under another man's name. That is the first thing to understand about him. The second is that his own name is close to the most anonymous one an American man can carry. The silver dollar connects the two. Brown spent his career guarding things that were not quite his, a reputation, a balance sheet, a founder's surname on the door, and making them grow without spending what he didn't have to. For a long time that included the credit.
By the Numbers
The Brown Years at Stryker
$17M → $6.7BStryker revenue, from Brown's arrival in 1977 to his retirement as chairman
32Years as CEO, chairman, or both
1979Year of the IPO and the Osteonics acquisition, Stryker's entry into orthopedic implants
$1.9BPrice paid for Pfizer's Howmedica division in 1998, the largest deal of his tenure
20%Annual earnings growth Brown set as the standard and, by trade-press accounts, sustained
5.3%Brown's listed stake in Stryker, larger than any holder named Stryker
$1.1BNet worth on the 2005 Forbes 400 (rank No. 320)
The Commonest Name in the Index
Type his name into the encyclopedia and it refuses to choose. The disambiguation page for "John W. Brown" lists a British trade unionist who became general secretary of the International Federation of Trade Unions, a New York congressman born in Dundee in 1796, a set decorator whose career is dated only to "the 1960s–1970s" and who won an Oscar for the art direction of Camelot, a Middlesbrough MP, a wartime pitcher, an English stained-glass designer, an Ohio governor, and two ships. Somewhere among them is "John W. Brown (corporate executive)," with no birth year and no death year, only the scholar's abbreviation fl., flourished, followed by "1980s–2010s." That is how medieval chroniclers are dated, people known by their works because nobody recorded when they were born. Here it describes a man whose company's products, by its own count, now reach 150 million patients a year.
The wider page for plain "John Brown" runs to several hundred entries. There is the abolitionist, of course, whose raid on Harpers Ferry in October 1859 is the first thing most Americans think of when they hear the name. There are footballers in three codes, a Cherokee chief, a Seminole chief, a fugitive slave who wrote a memoir, a Scottish servant who became Queen Victoria's closest friend, and a Sheffield steelmaker whose company built the Lusitania. Down a side path is J.W. Brown, a Louisiana bassist and Jerry Lee Lewis's cousin. On July 28, 1957, on The Steve Allen Show, he became the first person to play an electric bass on television. Five months later he learned that his thirteen-year-old daughter had secretly married Lewis, and he drove to Sun Studios with a pistol.
This is not trivia. It is the condition the subject worked under. A man named Homer Stryker can put his name on a bed, and in time the bed is simply called "the Stryker Frame." A man named John W. Brown cannot. The name won't hold anything. It is too common and too shared, already used up on raids and ballads and Liberty ships, so the only place to put the work is the institution. Whether Brown ever thought of it in those terms, I don't know. He never said so in any interview I could find. But the arrangement suited him, and he seems to have liked it.
A Dead Man's Company
The company he inherited had been built by a doctor who couldn't stand bad equipment.
Homer Stryker was born in 1894 and spent eight years as a general practitioner in Kalamazoo. Then, at an age when most doctors are settled, he went to Ann Arbor for a three-year orthopedic residency at the University of Michigan and came home in 1940, at forty-five, to practice his new specialty. Almost at once he started fixing the tools of his trade. He found that orthopedic devices served neither the patient nor the nurse especially well, which other surgeons also noticed, but unlike them he built replacements. The first was the Wedge Turning Frame, a mobile bed that pivoted so an immobilized patient could be repositioned without being moved. Next came a motorized cast cutter that oscillated instead of spinning, so it went through plaster without going through skin, and a walking heel for leg casts. In 1941 he formed the Orthopedic Frame Company to sell them. During the war, according to one company timeline, the Army ordered turning frames in such numbers that Stryker contracted a local toy-wagon factory to help build them. A child's wagon line repurposed to roll wounded soldiers onto their sides is the kind of fact that sounds invented. It isn't, or at least the company's own chroniclers don't think so.
His rule was simple and severe. Every product had to make the caregiver more efficient or make care cheaper. Sales reached $1 million in 1958. His son Lee became general manager in 1955 and president in 1969. The name changed to Stryker Corporation in 1964, the year the doctor retired from medicine.
In 1976 Lee Stryker, his wife Nancy, and two family friends were killed in a plane crash in Wyoming.
That year mattered for a second reason. Brown later recalled it with the precision of a man who had spent his working life inside the consequences: "The medical devices were put under the FDA on May the 28th, 1976, by Paul Rogers, a congressman from Florida." The Medical Device Amendments, written by Rogers, changed the industry's rules in the middle of the game. A company that had been one surgeon's workshop was now a regulated manufacturer, and it had lost its operating head. The founder was in his eighties. Sales were somewhere between ten and seventeen million dollars depending on which year you count, and there were a few hundred employees. Brown remembered the product line simply: "primarily stretchers—emergency room stretchers and powered instruments and [a] cast cutter."
He arrived in February 1977 as president and chief executive. Dr. Stryker died in 1980, at eighty-five, and Brown became chairman. He held that title until his retirement, which means that for nearly three decades the man who ran Stryker was not a Stryker. An interviewer once asked him, gently and with the bluntness that politeness requires: But did you feel some obligation to continue the legacy of the Stryker name?
Whatever he answered, the record of what he did is clearer. He kept the name and replaced the method. The doctor had invented products. Brown would buy companies, divide them, measure them, and leave them alone.
Getting By
He was the eldest of five, born in the Depression. Working back from the age Forbes gave him in 2005, that makes it about 1934. The family farmed because his father had no other work. "Because I was the eldest," he said, "I was treated like an adult from about the age of two."
— John W. Brown, to *Orthopedics This Week*, December 2009These early experiences were so heavily laden with thoughts of 'getting by' that I have always strongly believed in preserving assets.
Then his mother contracted tuberculosis. She spent about four years in a sanitarium. The family was split up. Some of the younger children went to live with relatives, and John stayed with his father on the farm. "All the while we were farming for a living, something I swore I would get away from," he said. "The work was 24/7 and you just never got caught up."
You just never got caught up. Remember that sentence when you look at the number Brown made famous at Stryker, twenty percent earnings growth every year. On a farm, the work never ends and the debt is never paid off. Brown's later management can be read as an attempt to build the reverse: a system that always gets caught up, that closes its books each year a fixed distance ahead of where it started, and that never sends the children off to relatives.
He finished high school in 1953 and went to a nearby junior college, where he met a chemistry student named Rosemary. When the friends from that group transferred to Auburn University, the reason was practical. "One of our 'gang' was from Alabama," Brown said, "and had a car." That is how the future of a Fortune 500 company was decided, by whoever had the car. He took a chemical engineering degree, she took chemistry, and they married the year they graduated. Rosemary Brown later earned a master's degree in mathematics education from Rutgers and taught math in East Brunswick, New Jersey, and in Kalamazoo. Two chemists, then, married young, who had both grown up near where a few dollars could decide things. Their marriage was a partnership, and it shows in what they later chose to fund.
Apprenticeships in Other People's Plants
Brown's résumé before Stryker shows a man learning operations in places where nobody owed him anything.
First came Ormet, an aluminum company. "The metals business in the '40s and '50s was a rough and tumble world," he said. "The majority of people I worked with were former miners from West Virginia, a proud, headstrong bunch." This is where he picked up the management style he would use for the rest of his life, though he described it as a lesson in getting along. "These years taught me how to get along with people who lacked a formal education, but were smart and held strong opinions."
— John W. Brown, on his years at OrmetLearning how to get along with these guys and appreciate their life goals made me a better man and a better manager. I have observed a lot of CEOs over the years, and the smart ones realize that the best way to achieve success is to be a servant of the organization.
West Virginia miners keep turning up in this story. Brown's coworkers were the sons and grandsons of men who had fought the coal operators in the Paint Creek–Cabin Creek strike of 1912–13. One of the agitators jailed in that strike was also named John W. Brown, and we'll come back to him.
In 1962 Brown left for Thiokol Chemical, which ran the Longhorn Army Ammunition Plant in Texas and developed and manufactured solid rocket propellant. "It was a great place for an engineer," he said. Within three years he had survived "a couple of layoffs" and decided that surviving layoffs was not a career. In 1965 he joined Squibb, which he called a "business boot camp." He held several management jobs there, including assistant to the president, and learned how a product gets from a lab bench to a hospital shelf. In 1972 Squibb made him president of its surgical subsidiary, Edward Weck & Company. He ran it for five years. Then the call came from Kalamazoo.
So the man who took over Stryker at about forty-three had worked with aluminum, rocket fuel, pharmaceuticals, and surgical supplies. That is four industries in fifteen years, each with its own hazards, each teaching him something about plants and the people who run them. He was no inventor and no surgeon, and he never pretended to be either. What he knew was how plants run and who actually runs them.
Other Men's Names
There is a ship in Baltimore called the John W. Brown. It has nothing to do with Stryker, but it says a good deal about the name.
The U.S. Maritime Commission ordered hull number 312 on May 1, 1941. Workers at the Bethlehem-Fairfield Shipyard laid her keel on July 28, 1942, and launched her on Labor Day, September 7. She was the third Liberty ship to slide off the ways at that yard that day, and one of six launched nationwide that Labor Day, all named for labor leaders. Naming ships after union men was partly an incentive for the riveters. Her sponsor was Annie Green, wife of the president of the Industrial Union of Marine and Shipbuilding Workers. She was finished on September 19, fifty-four days after her keel was laid. She took about 500,000 man-hours, cost $1,750,000, and was the 62nd of 384 Liberty ships the yard would build. Her engine, a triple-expansion steam plant from Worthington Pump in Harrison, New Jersey, cost $100,000. Shipbuilding had become assembly-line work, and her namesake would probably have had opinions about that.
He was another John W. Brown. Born in Canada around 1870, he moved to Maine, started as a joiner at Bath Iron Works, and became an American citizen in 1896. He went into the labor movement, organized, and struck when he thought he had to. From 1936 to 1940 he wrote a union column called "Workers Should Know." In 1941, semi-retired and advising Local 4 of the same shipbuilders' union whose president's wife would later break a bottle on his ship's bow, he died of an accidental shotgun wound. His grandson told the story in 2002. A whippoorwill had been keeping the household awake. Brown took the gun outside and told his wife, I'll get that damn thing if it kills me.
The ship's preservationists note that he and his wife, Eva, raised three daughters in a house in Woolwich, across the river from Bath. In March 1913, a socialist organizer named John W. Brown, held by the West Virginia militia in a "bull pen" at Pratt alongside Mother Jones during the Paint Creek strike, wrote a letter home that began My Dear Eva. In it he explained why he refused to recognize the military court: "If it was only myself personally that was concerned I would, for the sake of gaining my liberty and being free to go to you and the children, go before this court and defend myself… But my dear, there are principles involved in this case infinitely deeper than the fate of any one citizen." I can't prove that the Maine joiner and the West Virginia prisoner were the same man. Their wives had the same name, they had the same politics, they belonged to the same generation, and they had the same stubbornness. That is all I have. With a name this common, coincidence is cheap.
The ship outlived him by a very long time. She made thirteen voyages between 1942 and 1946. On her maiden voyage she carried two P-40 fighters, ten Sherman tanks, two hundred motorcycles, a hundred jeeps, more than seven hundred tons of ammunition, and more than 250 long tons of canned pork to the Persian Gulf for the Soviet Union. She went the long way, around Cape Horn and Cape Town, and arrived on Christmas Day 1942. She was the first of 220 Liberty ships converted into a "Limited Capacity Troopship," fitted with bunks stacked five deep. She carried nearly ten thousand troops in all, including the all-Black 758th Tank Battalion and two shiploads of German prisoners from the Afrika Korps. On February 22, 1944, U-969 torpedoed the Peter Skene Ogden, five hundred yards ahead of her, and the George Cleeve, 850 yards off her starboard bow. Both were total losses. The Brown was untouched. She arrived off southern France ten hours after the first Dragoon landings. On her seventh voyage she reached the Downs on V-E Day. Her full war record fills a book, Liberty Ship: The Voyages of the John W. Brown, 1942-1946. Then she spent thirty-six years tied up in Manhattan as a floating vocational high school. Between 1951 and 1955, 80 percent of its graduates went into maritime or seagoing government work, a record that rivaled the United States Merchant Marine Academy's. Today she is a museum ship, kept running by volunteers.
The Sheffield John Brown is the hardest of these stories to read. He was born in 1816, the son of a slater, and refused his father's plan to make him a draper. At twenty-one he borrowed £500 to become a sales agent for a steel firm, then built the Atlas Steel Works. He patented a railway buffer, adopted the Bessemer process, and in 1863 became the first to roll twelve-inch armour plate for warships. By 1867 most of the Royal Navy was clad in his steel, he employed more than four thousand people, and turnover was nearly £1 million. He took on partners, fell out with them, and resigned in 1871. Every venture he started afterward failed. He died poor in 1896, at eighty. The company that kept his name went on to build the Lusitania, the Hood, the Queen Mary, and the QE2. His name ended up on some of the most famous ships ever built, and he had nothing.
The Ohio John W. Brown is the comic version. He was a lieutenant governor who had just lost a gubernatorial primary to C. William O'Neill, 72.5 percent to 27.5, when a quirk of the calendar made him governor. Frank Lausche left for the U.S. Senate on January 3, 1957, and O'Neill couldn't be sworn in until January 14. Brown made the most of his eleven days. He moved into the governor's mansion, called the General Assembly together to hear a State of the State address, collected the governor's salary for the period, and deposited five boxes of gubernatorial papers with the Ohio Historical Society. Among them were a letter on official letterhead asking the mayor of Columbus to take care of a parking ticket and a letter asking President Eisenhower for a federal job once the eleven days were up.
Four men with one name. One invented the steel and lost his fortune while his name sailed on. One fought for the men who built ships and got a ship named after him. One held a title for eleven days and treated it as permanent. And one, from West Tennessee, spent thirty-two years building something with another man's name on the front and was content to be listed as fl.
I Was the Obstacle
The most revealing thing Brown ever said about his own management was an admission of failure.
— John W. Brown, reflecting on his early years at StrykerEarly on, I was insistent on making all of the decisions on everything, and then it struck me about three or four years down the road that I was the obstacle.
Three or four years after February 1977 puts the realization around 1980 or 1981, exactly when he became chairman and when Stryker, newly public after its 1979 IPO, was buying its way into implants and endoscopy. A CEO who meets his first acquisitions by deciding to stop making decisions is unusual. Most do the opposite and tighten their grip as the organization grows past them.
The structure he built made that admission into an operating system. By the late 1990s Stryker was organized into ten separate divisions, among them Howmedica Osteonics, Stryker Endoscopy, Stryker Instruments, Stryker Medical, Physiotherapy Associates, and Matsumoto Medical Instruments, and the company's own descriptions said each "operates as its own entity." Headquarters asked for one thing. Brown described it in a sentence that sounds less like strategy than like a farmer laying down rules for grown sons: "As long as they met their financial standards, they were free to go."
The standard was a number, and the number was twenty percent. Orthopedics This Week described him as the man who led Stryker "to 20% earnings—and [kept] it there," and on Wall Street, where Stryker eventually became known as a dependable compounder, that steadiness was the reputation. Asked for the logic of the system, one of his longtime executives, a man named Johnson who spent a decade as group president of the MedSurg unit, reached for a pair: (He felt) if he gave the right people those two things, it would inspire them to the highest level of performance. The surviving fragment of that interview doesn't say what the two things were. Given everything else, it's hard not to guess freedom and a number.
"Many of us," the fragment continues, "accomplished more than we ever thought possible."
The obvious danger in such a system is that a number becomes a master, that divisions told to hit twenty percent will find ways to hit it that headquarters would rather not hear about. That danger arrived late, after the system had worked for a very long time. Its first effect was the opposite. Ambitious division heads were given room, and a midsize Michigan company spread across Europe and Asia without its chairman having to approve every hire in every country.
Buying the Bones
Dr. Stryker had invented. Brown bought.
The first purchase came in 1979, the IPO year, and it decided the company's future. "We acquired a company up in New Jersey called Osteonics," Brown recalled, "which was owned by a couple of engineers." Osteonics made replacement hips and knees, and with it Stryker went from moving patients around to putting metal inside them. That is a different business, with different margins, different regulators, and different litigation. In 1981 came SynOptics and endoscopy. In 1992 came Dimso, a French spinal-fixation company. In 1994 Stryker introduced its RUGGED ambulance cots and moved into emergency medical services. In 1996 it bought Osteo SA and entered orthopedic trauma. In 1997, after eighteen years on NASDAQ, Stryker listed on the New York Stock Exchange.
The pattern before 1998 was small companies, mostly engineer-founded, mostly bought into adjacent markets. They had to be companies that fit inside a division and could be judged by a division's standard. Then, in August 1998, Brown broke the pattern on purpose and bought Pfizer's orthopedic division, Howmedica, for $1.9 billion. The Wall Street Journal, the New York Times, and the Irish Times all ran the deal. Howmedica merged with the 1979 purchase to become Howmedica Osteonics, and Stryker became one of the major orthopedic companies in the world. Sales for 1998 reached $1.1 billion, with 10,974 employees. The company had crossed the billion-dollar mark twenty-one years after Brown arrived to run a stretcher maker.
It is the one moment in his career when the silver dollar left the pocket. It was also a familiar kind of deal for him: a big pharmaceutical company's neglected surgical unit, the sort of division Brown himself had run at Squibb, picked up by a man who knew what such a unit could do once it was free of a parent that didn't care about it.
After 2000 the acquisitions came steadily. Stryker entered surgical navigation. Surgical Dynamics' spinal implant business came in 2002 for $135 million, and SpineCore and its artificial discs in 2004 for $120 million. Forbes, which writes its summaries in puns, said SpineCore "should provide the backbone for continued growth." By 2005 sales were $3.6 billion. By 2009, the year he announced his retirement, they were $6.7 billion.
The Trialers Are Waiting
Asked which obstacle had been hardest, Brown named the regulator without hesitation: "I would say, in my day, it was primarily the FDA was the most difficult hurdle that we had to get over, but CMS is becoming equally potent as far as being able to get reimbursements." Elsewhere, in a fragment I can't place in context, he named the other enemy: "the trialers are waiting with bated breath to descend upon you if you make one tiny mistake."
Brown's career fits almost exactly inside the era of federal device regulation. He took over Stryker eight months after Paul Rogers's amendments became law, so he never ran a medical company that wasn't answerable to Washington. He served as a director of the Health Industry Manufacturers Association and of AdvaMed, its successor, as a trustee of the Food and Drug Law Institute, and as chair of the Institute for Health Technology Studies. He understood the rules well, the way a West Tennessee farmer understands the weather.
That makes the end of his tenure uncomfortable to write about, and it would be dishonest to skip it.
In 2007 and 2008, with Brown still chairman and Stephen MacMillan, who had arrived in 2003, in the chief executive's chair, Stryker received three FDA warning letters. The first, seven pages long, cited an Irish plant for slow fixes and procedural failures in testing problem devices. The second, in November 2007, cited the Mahwah, New Jersey, facility: poor fixation of hip-implant components, in some cases requiring revision surgery, microbial levels above limits in the cleaning and final-packaging areas for sterile implants, and failure to prevent recurrence. The third, in April 2008, cited the biotech facility in Hopkinton, Massachusetts, and included falsified documents. The company said the employees involved had been fired. In August 2010 Stryker paid $1.35 million to settle claims that it had marketed products without regulatory approval. MacMillan resigned in February 2012. That year brought a recall of the Rejuvenate hip, followed by years of litigation over Rejuvenate and the ABG II, and in 2013 a $13.2 million settlement of charges over improper payments in five countries.
Most of this happened after Brown's watch. Some of it happened while he was still chairman. None of it is proof that the system he built was rotten. A company with ten autonomous divisions and tens of thousands of employees will produce some failures by sheer numbers. But it would be naive to pretend the two facts are unrelated. A system that tells division heads they are free as long as they hit twenty percent works well until a division decides that the number matters more than the cleaning logs. Freedom plus a target is a powerful combination, and it puts all its trust in the people who receive it. Brown saw that the founder-style CEO was "the obstacle." The trouble is that the obstacle was also the last check.
Shade You Do Not Expect to Sit In
He handed over gradually. MacMillan came in 2003 and held the chief executive's title by 2005, and Brown stayed on as chairman, a pattern he would describe late in life with characteristic economy: "At my age, it seemed appropriate, so they agreed." On October 30, 2009, Stryker announced he would retire. In 2010 he became Chairman Emeritus, and Stryker's later histories give him one line each: 1977, president and CEO; 1980, chairman; 2010, retired. Asked how he wanted to be remembered, he chose institution over individual: "as an individual that was involved in building Stryker from a little company to really a giant in the medical technology field." Involved in. Even here he gave himself a modest role.
The Browns had moved to Michigan in the late 1970s and stayed. He served on the Kalamazoo College board from 1980 to 1995, she from 1998 to 2009. They endowed a professorship in mathematics and computer science in Rosemary's name and later committed $5 million to a scholarship fund for students "of all socioeconomic backgrounds," which is the polite modern way of saying for children whose fathers carry one silver dollar to town. They also gave to engineering, the sciences, the performing arts, and veterinary medicine. Their own statement about the gift was very Midwestern: "attending the Boys' tennis tournaments, the concerts, the Kitchen lectures…we are happy to play a role." They chose a line from Nelson Henderson as their motto: The true meaning of life is to plant trees, under whose shade you do not expect to sit.
Five hundred miles southeast, in Baltimore, the ship with his name is still being looked after by men who expect no shade either. When Ernest F. Imhoff chronicled her restoration in Good Shipmates: The Restoration of the Liberty Ship John W. Brown, the average age of her volunteer crew was well over seventy. A photograph from the book shows Joe Carbo, eighty, in the engine room. On August 24, 1991, after three years of volunteer work, she steamed under her own power for the first time in nearly forty-five years, over the same Chesapeake waters where she had run her first sea trials in 1942. In 2019 her pier lease shrank without warning to six weeks, and her volunteers went looking along the Baltimore waterfront for a berth big enough for a 441-foot ship and found fewer than a dozen. Nobody in Kalamazoo, as far as I know, ever had anything to do with her. She is named for a different John W. Brown. The work of keeping her going is the same kind of work.
The Stryker Corporation now reports more than $25 billion in revenue and 53,000 employees, sells in more than seventy-five countries, and sits at No. 195 on the Fortune 500. Its ownership table lists John W. Brown first among named holders, at 5.3 percent, ahead of Ronda Stryker, who carries the founder's name, at 4.6. Ronda Stryker sits on the board. Brown's name appears in the encyclopedia between a labor leader and a set decorator, with no dates, only fl.
The rest of the story is a Saturday in West Tennessee. A man who had lost his job at a General Motors subsidiary in 1929 goes into town with a silver dollar in his pocket, buys what he has to, and starts home. His eldest son, treated like an adult since he was two, is waiting in a field that never got caught up. The man's hand is in his pocket, and the coin is still there.
Part IIThe Playbook
What follows is an attempt to pull operating principles from Brown's thirty-two years without turning them into slogans. His record contains real achievement and real warnings: decades of compounding, and at the end a run of warning letters that his own system may have helped bring about. Both are lessons. Most of the principles below concern what a non-founder CEO can do that a founder can't, and the specific risks of the method that made him effective.
The principles
- 1.Keep the founder's name; replace the founder's method.
- 2.Carry capital to town hoping to bring it home.
- 3.Find the obstacle in the mirror by year four.
- 4.Trade freedom for a number.
- 5.Make the target boring, then make it permanent.
- 6.Buy engineers until you find the empire worth buying.
- 7.Learn to manage people who don't need you.
- 8.Collect apprenticeships in unrelated plants.
- 9.Treat regulation as terrain, not weather.
- 10.Audit what the number is doing to the people chasing it.
- 11.Leave in stages, and let the stages be visible.
- 12.Fund the shade, not the monument.
S
The Brown Era at Stryker
Key decisions across thirty-two years, from stretcher maker to orthopedic giant.
1976
Lee Stryker killed in a Wyoming plane crash; on May 28, medical devices come under FDA authority.
1977
Brown, president of Squibb's Edward Weck & Company, becomes Stryker's president and CEO in February.
1979
IPO; acquisition of Osteonics brings Stryker into orthopedic implants.
1980
Dr. Homer Stryker dies at 85; Brown becomes chairman.
1981
SynOptics acquisition opens endoscopy.
1992
Dimso acquisition enters spinal fixation.
1996
Osteo SA brings Stryker into orthopedic trauma.
1997
Moves to the NYSE after 18 years on NASDAQ.
1998
Buys Pfizer's Howmedica for $1.9 billion; sales reach $1.1 billion.
2003
Stephen MacMillan arrives; holds the CEO title by 2005.
2009
Brown announces retirement; revenue stands at $6.7 billion.
Principle 1
Keep the founder's name; replace the founder's method
Brown arrived at a company built on one surgeon's inventions and his rule that every product must save caregiver time or cut cost. He kept the name, which by then stood for something in every hospital that used a turning frame. He didn't try to compete with the founder at the founder's own game. He was no surgeon and invented nothing. He used a different way of growing, through acquisition, decentralization, and financial discipline, which needed no inventor's genius and so didn't depend on the one man the company had nearly lost.
Successors to founders often make one of two mistakes. Some rebrand to put their own stamp on the place. Others imitate the founder's habits and keep running a workshop that is turning into a corporation. Brown did neither. The surname stayed on the door, so customers kept their trust in it, while the company underneath was rebuilt.
Tactic: When you inherit a founder's company, write down separately what the brand promises customers and how the founder actually produced it, then keep the first and feel free to rebuild the second.
Principle 2
Carry capital to town hoping to bring it home
Brown tied his frugality to a specific memory, a silver dollar his father took to town each Saturday hoping not to spend it, and to a specific fear: "if I managed things incorrectly, people's lives might be drastically affected." For him frugality wasn't about appearances. It came from knowing what happens to a family when the money runs out, which in his case meant a mother in a sanitarium for four years and siblings sent to relatives.
That is why the Howmedica deal, at $1.9 billion, stands out. A man that careful will make a large bet only when it is clearly the right one. For two decades the acquisitions were small, mostly engineer-founded, and mostly adjacent to what Stryker already did. The big check came once, in 1998, and it made Stryker one of the leading orthopedic companies in the world.
Tactic: Treat every capital commitment as money you intend to bring home, so that the rare big bet is obviously different from routine spending.
Principle 3
Find the obstacle in the mirror by year four
"I was the obstacle." Brown reached this about three or four years into the job, around the time Stryker went public and started acquiring. The timing matters. A centralized CEO can run a single-product company of a few hundred people. He can't run a company that owns a New Jersey implant maker, an endoscopy business, and a growing list of international operations.
What's notable isn't that he noticed. Plenty of executives notice. It's that he changed course in his first job as a chief executive, when the instinct to hold on is strongest.
Tactic: Once a year, list every decision that waited on you in the last quarter, and ask which of them stalled because of you rather than because of the decision itself.
Principle 4
Trade freedom for a number
"As long as they met their financial standards, they were free to go." The whole system is in that sentence. Stryker's divisions, ten of them by the late 1990s, each run "as its own entity," were measured from headquarters on financial performance and otherwise largely left alone. One longtime executive remembered the deal as giving the right people two things that would inspire "the highest level of performance."
The arrangement attracts and keeps operators who want to run something. It also scales: a chairman who checks one figure per division can oversee many more divisions than one who checks a hundred.
B
Centralized founder vs. Brown's decentralized model
How the operating logic shifted after 1977.
| Dimension | Founder era | Brown era |
|---|---|---|
| Source of growth | Invention by the founder | Acquisition and divisional expansion |
| Decision rights | Concentrated at the top | Pushed to division heads |
| Control mechanism | Personal judgment | Financial standards, roughly 20% earnings growth |
| Primary risk | Key-person dependency | Divisions gaming or neglecting what the number omits |
Tactic: Give each unit leader one explicit financial standard and real authority over everything else, and put both halves of the deal in writing.
Principle 5
Make the target boring, then make it permanent
Twenty percent is not a visionary number. It reads more like a quota than a mission. That was the point. A target that never moves lets the organization stop arguing about goals and put its energy into meeting them. Orthopedics This Week singled out not that Brown reached twenty percent earnings growth but that he kept it there.
There is a psychological side as well, one Brown hinted at when he described the farm: "you just never got caught up." A fixed, repeatable target gives everyone a way to finish each year. Investors get predictability, managers get a known yardstick, and the chairman gets an annual sense of having caught up.
Tactic: Choose one growth figure you can defend for a decade and stop renegotiating it every planning cycle.
Principle 6
Buy engineers until you find the empire worth buying
The 1979 Osteonics deal was a small company "owned by a couple of engineers," and it took Stryker into implants. The deals that followed, SynOptics, Dimso, Osteo SA, were the same kind: focused, technical, small enough to fit inside a division. Each widened what Stryker could do without straining its balance sheet. Then came the exception, Howmedica, a neglected division of Pfizer bought outright.
The sequence is what makes it work. Twenty years of small deals taught the company how to absorb technical businesses. By 1998 it knew how, so the big deal had a place to go. The Howmedica name survives as half of Howmedica Osteonics, with the big acquisition fused to the first small one.
Tactic: Build your integration skill on a series of small technical deals before you attempt the transformational one, so the large deal arrives in a company that already knows how to absorb acquisitions.
Principle 7
Learn to manage people who don't need you
The miners at Ormet were "a proud, headstrong bunch," with no formal education, plenty of intelligence, and strong opinions. A young chemical engineer couldn't impress them with his degree. He had to learn to "appreciate their life goals." Brown said those years made him "a better man and a better manager" and taught him that "the best way to achieve success is to be a servant of the organization."
Division heads given real autonomy are, in a sense, people who don't need you. A CEO who has only managed people dependent on his approval will find decentralization frightening. Brown had done it in an aluminum plant first.
Tactic: Early in your career, look for at least one assignment managing people who have no reason to defer to you, and treat it as training for leading senior executives later.
Aluminum at Ormet. Solid rocket propellant at Thiokol's Longhorn Army Ammunition Plant. Pharmaceuticals and logistics at Squibb. Surgical products as president of Edward Weck from 1972 to 1977. Each taught something different: labor relations, how hazardous manufacturing behaves, what it takes to get a product to market, and finally how to run a full operation. Surviving "a couple of layoffs" at Thiokol taught him something too.
When Stryker called, Brown wasn't a specialist in its products. He knew how plants run and how a unit runs inside a large parent, and that is the knowledge you need to buy and integrate other companies' plants.
Tactic: Move across industries early on purpose, and judge each move by the operating lesson it gives you rather than by the title.
Principle 9
Treat regulation as terrain, not weather
Brown could recite the date the FDA got authority over devices, May 28, 1976, and the name of the congressman responsible. He named the FDA as his hardest hurdle and saw CMS, the reimbursement authority, becoming "equally potent." He served on the boards of HIMA and AdvaMed and as a trustee of the Food and Drug Law Institute.
The point is not lobbying. Regulation was a permanent feature of his market, to be mapped and studied the way a farmer studies soil, rather than an occasional storm to complain about. A company that sees regulation as weather reacts to it. A company that sees it as terrain plans its route across it.
Tactic: Assign someone senior to track how the rules in your market are likely to change over the next five years, and review that outlook as seriously as you review the competition.
Principle 10
Audit what the number is doing to the people chasing it
This principle comes from the end of the story. In 2007 and 2008, with Brown still chairman, Stryker received three FDA warning letters: hip-implant fixation problems and microbial violations at Mahwah, slow remediation in Ireland, and falsified documents at Hopkinton. Settlements, recalls, and an FCPA case followed, mostly after he left.
A system built on "freedom plus a number" depends entirely on the integrity of the people given the freedom. When a division falls short, the easiest thing to cut is whatever the number doesn't measure: cleaning logs, documentation, the slow work of preventing problems from recurring. A strength of the model, that headquarters doesn't watch everything, is also its weakness.
!
Where decentralized compounding breaks
Categorizing the risks hidden inside a freedom-for-a-number system.
| Signal | What it may mean | Category |
|---|---|---|
| Regulatory warning letters at multiple sites | The problem is the system, not one local lapse | Risk |
| Documentation irregularities | Pressure to hit the target is being passed down to the people least able to resist it | Risk |
| Targets hit year after year without variance | Excellence, or quiet smoothing; check which | Try |
| Independent quality function reporting outside the divisions | A check the number cannot buy off | Scale |
Tactic: Pair every financial target with a quality or compliance function that reports outside the division and cannot be overruled by the people being measured.
Principle 11
Leave in stages, and let the stages be visible
Brown didn't leave all at once. MacMillan arrived in 2003 and had the CEO title by 2005. Brown stayed as chairman until announcing his retirement in October 2009 and became Chairman Emeritus in 2010. "At my age, it seemed appropriate, so they agreed." Staged departures let a company test a successor while the predecessor is still around.
The staged approach doesn't guarantee a good outcome. MacMillan resigned in February 2012, and the company went through an interim CEO and a non-executive chairman before Kevin Lobo was appointed that October. But a gradual handover at least shows any weaknesses in public, while the people who can fix them are still there.
Tactic: Announce your succession in phases with defined handoff points, so the board can judge the successor while you are still available to step in.
Principle 12
Fund the shade, not the monument
The Browns' motto came from Nelson Henderson: plant trees "under whose shade you do not expect to sit." Their giving followed it. They endowed a professorship in Rosemary's name in mathematics and computer science and created a $5 million scholarship for students "of all socioeconomic backgrounds." They gave across engineering, the sciences, the arts, and veterinary medicine, with no gift calling for a skyscraper bearing the family name.
This is consistent with the rest of his career. He built a giant company under someone else's name, and he gave the same way, funding what helps people rather than what advertises the giver.
Tactic: Direct your giving toward things that compound in other people, such as scholarships and teaching chairs, and judge each gift by who benefits in thirty years rather than by whose name is on it.
Free playbook
Get The Business Model Playbook
58 business models, one visual page each: how the money flows, the metrics that matter, and who runs it. Free when you join the Faster Than Normal email.
Free. No spam. Unsubscribe anytime.
Part IIIQuotes and Maxims
In their words
— John W. Brown, to *Orthopedics This Week*, 2009When I think of frugality, I think of my dad, who carried a silver dollar to town on Saturdays hoping that he wouldn't have to spend it.
— John W. Brown, on his management philosophyAs I gained responsibility in the business world, I was acutely aware that if I managed things incorrectly, people's lives might be drastically affected.
— John W. Brown, on Stryker's divisionsAs long as they met their financial standards, they were free to go.
— John W. Brown, on the regulatory environmentI would say, in my day, it was primarily the FDA was the most difficult hurdle that we had to get over, but CMS is becoming equally potent as far as being able to get reimbursements.
— John W. Brown, on how he wished to be rememberedI would want to be remembered as an individual that was involved in building Stryker from a little company to really a giant in the medical technology field.
Maxims
- Keep the name, change the engine. A founder's brand is a trust to keep, and the founder's way of operating is open to replacement.
- Bring the dollar home. Spend capital as if you mean to return with it, so the one big bet is unmistakable when it comes.
- Find the obstacle early. If decisions wait on you, the company's ceiling is your calendar, and you should fix that by year four.
- Freedom for a number. Give operators authority and one clear standard, then stay out of their way.
- Boring targets compound. A growth figure that never changes ends the arguments about goals and leaves the work.
- Small deals before big ones. Learn to integrate on modest technical acquisitions so the transformational deal has somewhere to go.
- Serve the organization. Learn to lead people who don't need you before you are given people who must obey you.
- Rules are terrain. Study regulators as permanent features of the market.
- Watch what the number omits. Every target creates a blind spot, so put someone outside the chain of command in charge of watching it.
- Plant trees. Build institutions and fund futures whose shade you won't sit in, and let the work carry your name more than your name does.
